Use the journals feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
JOURNAL ARTICLE
H Tang, X He, Y Chen, W Xu, J Yang, D Guo
No abstract text is available yet for this article.
April 13, 2024: Pulmonology
#2
LETTER
R Hindré, V Besnard, F Kort, H Nunes, D Valeyre, F Jeny
No abstract text is available yet for this article.
April 13, 2024: Pulmonology
#3
JOURNAL ARTICLE
A Müller, E F Wouters, P Koul, T Welte, I Harrabi, A Rashid, L C Loh, M Al Ghobain, A Elsony, R Ahmed, J Potts, K Mortimer, F Rodrigues, S N Paraguas, S Juvekar, D Agarwal, D Obaseki, T Gislason, T Seemungal, A A Nafees, C Jenkins, H B Dias, F M E Franssen, M Studnicka, C Janson, H H Cherkaski, M El Biaze, P A Mahesh, J Cardoso, P Burney, S Hartl, D J A Janssen, A F S Amaral
BACKGROUND: Dyspnoea is a common symptom of respiratory disease. However, data on its prevalence in general populations and its association with lung function are limited and are mainly from high-income countries. The aims of this study were to estimate the prevalence of dyspnoea across several world regions, and to investigate the association of dyspnoea with lung function. METHODS: Dyspnoea was assessed, and lung function measured in 25,806 adult participants of the multinational Burden of Obstructive Lung Disease study...
April 13, 2024: Pulmonology
#4
JOURNAL ARTICLE
Z Wang, F Xue, X Sui, W Han, W Song, J Jiang
BACKGROUND: Selecting the time target for follow-up testing in lung cancer screening is challenging. We aim to devise dynamic, personalized lung cancer screening schema for patients with pulmonary nodules detected through low-dose computed tomography. METHODS: We developed and validated dynamic models using data of pulmonary nodule patients (aged 55-74 years) from the National Lung Screening Trial. We predicted patient-specific risk profiles at baseline (R0) and updated the risk evaluation results in repeated screening rounds (R1 and R2)...
April 12, 2024: Pulmonology
#5
LETTER
M O Pinto, A S Santos, S Castanhinha
No abstract text is available yet for this article.
April 12, 2024: Pulmonology
#6
JOURNAL ARTICLE
S Safi, J Krzykalla, H Hoffmann, A Benner, H Bischoff, M Eichhorn, M Kriegsmann, I Poschke, F Stögbauer, L Umansky, C Mogler, W Weichert, H Winter, P Beckhove, T Muley
INTRODUCTION AND OBJECTIVES: Adjuvant platinum-based chemotherapy for completely resected non-small cell lung cancer is associated with modest improvement in survival; nevertheless, no validated biomarker exists for predicting the benefit or harm of adjuvant platinum-based chemotherapy. MATERIALS AND METHODS: We simultaneously measured 27 cytokines in operative tumor specimens from a discovery cohort (n = 97) by multiplex immunoassay; half of the patients received adjuvant platinum-based chemotherapy, and the other half were observed...
April 12, 2024: Pulmonology
#7
JOURNAL ARTICLE
Álvaro Fuentes-Martín, Luís Lourenço Graça
No abstract text is available yet for this article.
March 26, 2024: Pulmonology
#8
JOURNAL ARTICLE
Kun Wang, Zhuoheng Lv, Shuofeng Li, Hang Yi
No abstract text is available yet for this article.
March 26, 2024: Pulmonology
#9
EDITORIAL
M Mondoni, M M Wahidi, G Sotgiu
No abstract text is available yet for this article.
March 26, 2024: Pulmonology
#10
EDITORIAL
F Ramalho, A Oliveira, A Machado, V Azevedo, M R Gonçalves, G Ntoumenopoulos, A Marques
No abstract text is available yet for this article.
February 26, 2024: Pulmonology
#11
JOURNAL ARTICLE
P Laveneziana, Q Fossé, M Bret, M Patout, B Dudoignon, C Llontop, C Morélot-Panzini, F Cayetanot, L Bodineau, C Straus, T Similowski
INTRODUCTION AND OBJECTIVES: The human congenital central hypoventilation syndrome (CCHS) is caused by mutations in the PHOX2B (paired-like homeobox 2B) gene. Genetically engineered PHOX2B rodents exhibit defective development of the brainstem retrotrapezoid nucleus (RTN), a carbon dioxide sensitive structure that critically controls expiratory muscle recruitment. This has been linked to a blunted exercise ventilatory response. Whether this can be extrapolated to human CCHS is unknown and represents the objective of this study...
February 24, 2024: Pulmonology
#12
LETTER
T Silva, A Aguiar, A Gomes, M Marques, C Pereira, R Rodrigues, M Pinto, R Duarte
No abstract text is available yet for this article.
February 24, 2024: Pulmonology
#13
LETTER
R Vilarinho, C Ribeiro, V Abreu, S Souto-Miranda, F Silva, C Jácome
No abstract text is available yet for this article.
February 23, 2024: Pulmonology
#14
JOURNAL ARTICLE
Daniela Godinho, Marta Freixa, Filipe Froes
No abstract text is available yet for this article.
February 23, 2024: Pulmonology
#15
JOURNAL ARTICLE
T Villeneuve, C Hermant, A Le Borgne, M Murris, G Plat, V Héluain, M Colombat, M Courtade-Saïdi, S Evrard, S Collot, M Salaün, N Guibert
BACKGROUND AND OBJECTIVE: Traditionally, the diagnosis of acute rejection (AR) relies on invasive transbronchial biopsies (TBBs) to obtain histopathological samples. We aimed to evaluate the diagnostic yield of probe-based confocal laser endomicroscopy (pCLE) as a complementary and non-invasive tool for ACR screening, comparing its results with those obtained from TBBs. METHODS: Between January 2015 and April 2022, we conducted a retrospective study of all lung transplant recipients aged over 18 years at Toulouse University Hospital (France)...
February 23, 2024: Pulmonology
#16
REVIEW
D Mukhopadhyay, P Cocco, S Orrù, R Cherchi, S De Matteis
BACKGROUND: Asbestos is still the leading cause of occupational cancer mortality worldwide. Asbestos-related lung cancer (LC) and malignant pleural mesothelioma (MPM) prognosis is still poor especially at advanced stage, so early diagnosis biomarkers are needed. MicroRNAs (miRNAs) have been proposed as potential early diagnostic biomarkers of asbestos-related LC and MPM. AIM: To evaluate the role of miRNAs as diagnostic and prognostic biomarkers of asbestos-related LC and MPM by performing a literature systematic review and meta-analysis...
February 23, 2024: Pulmonology
#17
LETTER
S Ielo, A Campione, R Scala
No abstract text is available yet for this article.
February 23, 2024: Pulmonology
#18
LETTER
Limei Hu, Youjun Xie, Hongying Zhao
No abstract text is available yet for this article.
February 23, 2024: Pulmonology
#19
JOURNAL ARTICLE
P C Mota, M L Soares, A C Ferreira, R F Santos, J C Rufo, D Vasconcelos, A Carvalho, S Guimarães, F Vasques-Nóvoa, C Cardoso, N Melo, A T Alexandre, D Coelho, H Novais-Bastos, A Morais
INTRODUCTION AND OBJECTIVES: Hypersensitivity pneumonitis (HP) is an interstitial lung disease with diverse clinical features that can present a fibrotic phenotype similar to idiopathic pulmonary fibrosis (IPF) in genetically predisposed individuals. While several single nucleotide polymorphisms (SNPs) have been associated with IPF, the genetic factors contributing to fibrotic HP (fHP) remain poorly understood. This study investigated the association of MUC5B and TOLLIP variants with susceptibility, clinical presentation and survival in Portuguese patients with fHP...
February 2, 2024: Pulmonology
#20
JOURNAL ARTICLE
F P da Silva, G Samouco, F Fernandes
No abstract text is available yet for this article.
February 2, 2024: Pulmonology
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
